Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Nextcure Published Non-clinical Data Demonstrating NC605, An Anti-Siglec-15 Treatment Prevented Bone Loss Due To Immobilization From Acute Spinal Cord Injury

Author: Benzinga Newsdesk | December 21, 2023 08:07am

Posted In: NXTC

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist